Calcium Gluconate and Sodium Chloride Injection
On December 11, 2025, marketing approval was granted with the following approval numbers: National Drug Approval H20256177 and National Drug Approval H20256178.
| Description | This product is a colorless, clear liquid. |
| Specifications | 1.100ml: Calcium Gluconate 2g and Sodium Chloride 0.675g 2.50ml: Calcium Gluconate 1g and Sodium Chloride 0.3375g |
| Indications | Calcium Gluconate and Sodium Chloride Injection is indicated for the treatment of acute symptomatic hypocalcemia in children and adults. |
| Dosage and Administration | See the instructions for details. |
| Storage | Protect from light, store in a sealed container at no more than 30°C. |
| Marketing Authorization Holder | Jiangsu Yayo Biotechnology Co., Ltd. |
| Manufacturer | Anhui Fengyuan Pharmaceutical Co., Ltd. |
Glycerol Fructose and Sodium Chloride Injection
Received acceptance for the registration and marketing authorization application from Center for Drug Evaluation, NMPA on February 20, 2024.
| Description | This product is a colorless, clear liquid. |
| Specifications | 250ml: Glycerin 25g, Fructose 12.5g, and Sodium Chloride 2.25g |
| Indications | Treatment of increased intracranial pressure and cerebral edema; Improvement of consciousness disorders, neurological disorders, and subjective symptoms associated with increased intracranial pressure and cerebral edema due to the following diseases: cerebral infarction (cerebral thrombosis, cerebral embolism), intracerebral hemorrhage, subarachnoid hemorrhage, head trauma, brain tumor, meningitis; Treatment after neurosurgery; Brain volume reduction during neurosurgery; Situations where a reduction in intraocular pressure is needed; Eye volume reduction during ophthalmic surgery. |
| Dosage and Administration | See the instructions for details. |
| Storage | Store in a sealed container at no more than 20°C. |
| Marketing Authorization Holder | Jiangsu Yayo Biotechnology Co., Ltd. |
| Manufacturer | Zhejiang Guojing Pharmaceutical Co., Ltd. |
Peramivir Sodium Chloride Injection
|
Description |
This product is a colorless, clear liquid. |
|
Specifications |
100 mL: Contains 0.15 g of Peramivir (calculated as C₁₅H₂₈N₄O₄) and 0.9 g of Sodium Chloride. 100 mL: Contains 0.3 g of Peramivir (calculated as C₁₅H₂₈N₄O₄) and 0.9 g of Sodium Chloride. |
|
Indications |
This product is indicated for the treatment of Influenza A or B (Peramivir has demonstrated efficacy against both Influenza A and B; however, clinical data for Influenza B remain limited). The medication should be administered within 48 hours of the onset of initial symptoms. |
|
Dosage and Administration |
See the instructions for details. |
|
Storage |
Store in a sealed container at no more than 25°C. |
|
Marketing Authorization Holder |
Jiangsu Yayo Biotechnology Co., Ltd. |
|
Manufacturer |
Anhui Fengyuan Pharmaceutical Co., Ltd. |
